￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Is cabozantinib effective in lung cancer?

2025-10-19 11:44:20

Check Details
The effect of alectinib treatment on patients with lung cancer and brain metastasis

2025-10-19 11:44:20

Check Details
Erlotinib is a third-line treatment for non-small cell lung cancer

2025-10-19 11:44:20

Check Details
New choice for lung cancer: second-generation lung cancer targeted drug aletinib

2025-10-19 11:44:20

Check Details
Data on the efficacy of cabozantinib in patients with RET-rearranged lung cancer

2025-10-19 11:44:20

Check Details
Effects and side effects of erlotinib in the treatment of metastatic lung cancer

2025-10-19 11:44:20

Check Details
Targeted drug alectinib has significant effect in treating non-small cell lung cancer

2025-10-19 11:44:20

Check Details
What are the warnings from the body before lung cancer strikes, and what medicine should be taken

2025-10-19 11:44:20

Check Details
Erlotinib has good efficacy in metastatic non-small cell lung cancer

2025-10-19 11:44:20

Check Details
The second-generation ALK inhibitor, alectinib, is approved by the FDA as a first-line drug for ALK treatment

2025-10-19 11:44:20

Check Details
Has the anti-cancer drug cabozantinib been approved for marketing in China?

2025-10-19 11:44:20

Check Details
Treatment options for patients with metastatic lung cancer-erlotinib

2025-10-19 11:44:20

Check Details
Category
相关知识